About
News, Events & Presentations
Press Releases | Events Calendar | Presentations

Keyword Search
 
2017 | 2016 | 2015 | 2014
DateTitle 
11/18/14Fibrocell Science Announces IND Allowed to Proceed to Develop New Treatment for Wounded Warrior Amputees to Prevent Stump Skin DiseasesPrinter Friendly Version
11/07/14Fibrocell Science Reports Third Quarter and Nine Month 2014 Financial and Operating ResultsPrinter Friendly Version
10/30/14Fibrocell Science to Report Third Quarter 2014 Financial and Operating Results, and Host Conference Call and Webcast on November 7, 2014Printer Friendly Version
10/23/14Fibrocell Science Honored With 2014 Marcum Innovator of the Year AwardPrinter Friendly Version
10/03/14Fibrocell Science Announces Chief Financial Officer TransitionPrinter Friendly Version
09/30/14Fibrocell Science to Present at 2014 Stem Cell Meeting on the MesaPrinter Friendly Version
09/25/14Fibrocell Science to Present at BioCentury NewsMakers of the Biotech Industry ConferencePrinter Friendly Version
09/24/14Fibrocell Science and Intrexon Advance GM-HDF-COL7 toward Clinical Development for the Treatment of Recessive Dystrophic Epidermolysis BullosaPrinter Friendly Version
09/10/14Fibrocell Science Hosting R&D Day on September 24, 2014Printer Friendly Version
08/18/14Fibrocell Science, Inc. to Move Stock Listing to NASDAQPrinter Friendly Version
08/11/14Fibrocell Science Reports Second Quarter and First Half 2014 Financial and Operating ResultsPrinter Friendly Version
08/05/14Fibrocell Science to Present at Wedbush 2014 Life Sciences Management Access ConferencePrinter Friendly Version
08/04/14Fibrocell Science to Report Second Quarter 2014 Financial and Operating Results, and Host Conference Call and Webcast on August 11, 2014Printer Friendly Version
07/23/14Fibrocell Science Takes Active Role to Support Dystrophic Epidermolysis Bullosa Patient Advocacy GroupPrinter Friendly Version
06/17/14Fibrocell Science Announces Exclusive Technology License Agreements with UCLA to Advance the Development of Personalized Cell TherapiesPrinter Friendly Version
06/13/14Fibrocell Science Receives Orphan Drug Designation for Genetically-Modified Autologous Human Fibroblasts to Advance Treatment DevelopmentPrinter Friendly Version
06/02/14Fibrocell Science files Proxy Report on Form DEF-14A for the year ended December 31, 2013Printer Friendly Version
06/02/14Fibrocell Science files Annual Report on Form 10K/A for the year ended December 31, 2013Printer Friendly Version
05/29/14Fibrocell Science to Present at Jefferies 2014 Global Healthcare ConferencePrinter Friendly Version
05/28/14Fibrocell Science Announces Plans for Process Development and Manufacturing of Genetically-modified Cell Therapy for Rare Disease, RDEBPrinter Friendly Version
05/19/14Fibrocell Science Reports First Quarter 2014 Financial and Operating ResultsPrinter Friendly Version
05/16/14Fibrocell Science to Report First Quarter 2014 Financial and Operating Results, and Host Conference Call and Webcast on May 19, 2014Printer Friendly Version
05/12/14Fibrocell Science Announces Delay in Filing Quarterly Report on Form 10QPrinter Friendly Version
03/20/14Fibrocell Science to Present at 2nd Annual Regen Med Investor Day and BioCentury Future Leaders in the Biotech Industry ConferencePrinter Friendly Version
03/17/14Fibrocell Science Reports Fourth Quarter and Full Year 2013 Financial and Operating ResultsPrinter Friendly Version
03/10/14Fibrocell Science to Report Fourth Quarter and Full Year 2013 Financial and Operating Results, and Host Conference Call and Webcast on March 17Printer Friendly Version
03/05/14Fibrocell Science to Present at Barclays Global Healthcare Conference 2014Printer Friendly Version
01/13/14Fibrocell Science and Intrexon Expand Collaboration to Include Hypermobility-Type Ehlers-Danlos SyndromePrinter Friendly Version
01/06/14Fibrocell Science Appoints Robert Sheroff, Vice President of Technical OperationsPrinter Friendly Version



Printer Friendly Version E-mail this page RSS E-mail Alerts Download Financial Tear Sheet